Literature DB >> 14697474

Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals.

Iris Paula Garrido1, Debashis Roy, Ramon Calviño, Jose Manuel Vazquez-Rodriguez, Guillermo Aldama, Juan Cosin-Sales, Juan Quiles, David C Gaze, Juan Carlos Kaski.   

Abstract

This study compared ischemia-modified albumin levels, a marker of ischemia in patients undergoing percutaneous coronary intervention. Ischemia-modified albumin levels were significantly lower in patients with collateral circulation compared with those without collateral circulation.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14697474     DOI： 10.1016/j.amjcard.2003.09.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome.

Authors:  Andrew Worster; P J Devereaux; Diane Heels-Ansdell; Gordon H Guyatt; John Opie; Farouk Mookadam; Stephen A Hill
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

2.  Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.

Authors:  James Chek; Jaroslav Dusek; Josef Stasek; Jan Vojacek; Josef Bis; Martina Ulrychova; Milos Tichy; Tomas Tomko; Josef Bukac
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

3.  Ultrasonic Transducer-Guided Electrochemical Impedance Spectroscopy to Assess Lipid-Laden Plaques.

Authors:  Jianguo Ma; Yuan Luo; René R Sevag Packard; Teng Ma; Yichen Ding; Parinaz Abiri; Yu-Chong Tai; Qifa Zhou; Kirk K Shung; Rongsong Li; Tzung Hsiai
Journal:  Sens Actuators B Chem       Date:  2016-05-07       Impact factor: 7.460

4.  The usefulness of albumin-adjusted ischemia-modified albumin index as early detecting marker for ischemic stroke.

Authors:  Jung Hwan Ahn; Sang Cheon Choi; Wee Gyo Lee; Yoon Seok Jung
Journal:  Neurol Sci       Date:  2010-12-11       Impact factor: 3.307

5.  Ischemia-modified albumin in acute aortic dissection.

Authors:  Eftihia Sbarouni; Panagiota Georgiadou; Aikaterini Marathias; Demosthenes Panagiotakos; Stefanos Geroulanos; Vassilis Voudris
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain.

Authors:  Luciano Consuegra-Sanchez; Alberto Bouzas-Mosquera; Manas K Sinha; Paul O Collinson; David C Gaze; Juan Carlos Kaski
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

7.  The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome.

Authors:  Sangita M Patil; M P Banker; Ramchandra K Padalkar; Abhijit P Pathak; Sonali S Bhagat; Rahul A Ghone; Anjali S Phatake
Journal:  J Clin Diagn Res       Date:  2013-05-01

8.  Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests.

Authors:  June Hong Kim; Jae Hoon Choi; Hyun-Kook Lee; Woo Hyung Bae; Kook-Jin Chun; Yun Seong Kim; Sang Kwon Lee; Hyung Hoi Kim; Taek Jong Hong; Yong Woo Shin
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 3.165
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.